دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Diabetes in Pregnancy for Mothers and Offspring: Reflection on 30 Years of Clinical and Translational Research: The 2022 Norbert Freinkel Award Lecture
Anny H. Xiang
doi : 10.2337/dci22-0055
Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic
Wei Perng; Rebecca Conway; Elizabeth Mayer-Davis; Dana Dabelea
doi : 10.2337/dci22-0046
Longitudinal Continuous Glucose Monitoring Metrics During Healthy Pregnancy and Following Gastric Bypass
Helen R. Murphy
doi : 10.2337/dci22-0056
Roux-en-Y Gastric Bypass Increases Glycemic Excursions During Pregnancy and Postpartum: A Prospective Cohort Study
doi : 10.2337/dc22-1357
Race- and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and BMI in Youth With Diabetes
Mary Ellen Vajravelu; Iswariya Mani; Shehryar Malik; Brianna Hewitt; Vaishnavi Peyyety; Silva Arslanian
doi : 10.2337/dc22-1439
An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial
Felicia R. Simpson; Jamie N. Justice; Scott J. Pilla; Stephen B. Kritchevsky; Edward J. Boyko; Medha N. Munshi; Chloe K. Ferris; Mark A. Espeland; the Look AHEAD Research Group
doi : 10.2337/dc22-1728
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study
Darrell M. Wilson; Susan L. Pietropaolo; Maria Acevedo-Calado; Shuai Huang; Destiny Anyaiwe; David Scheinker; Andrea K. Steck; Madhuri M. Vasudevan; Siripoom V. McKay; Jennifer L. Sherr; Kevan C. Herold; Jessica L. Dunne; Carla J. Greenbaum; Sandra M. Lord; Michael J. Haller; Desmond A. Schatz; Mark A. Atkinson; Patrick W. Nelson; Massimo Pietropaolo; the Type 1 Diabetes TrialNet Study Group
doi : 10.2337/dc22-1297
Continuous glucose monitoring (CGM) parameters may identify individuals at risk for progression to overt type 1 diabetes. We aimed to determine whether CGM metrics provide additional insights into progression to clinical stage 3 type 1 diabetes.
Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes
Salma Nabila; Ji-Eun Kim; Jaesung Choi; JooYong Park; Aesun Shin; Sang-Ah Lee; Jong-koo Lee; Daehee Kang; Ji-Yeob Choi
doi : 10.2337/dc22-1042
Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control
Goran Petrovski; Judith Campbell; Maheen Pasha; Emma Day; Khalid Hussain; Amel Khalifa; Tim van den Heuvel
doi : 10.2337/dc22-1692
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes
Alessandra Giannella; Esmeralda Castelblanco; Carlo Federico Zambon; Daniela Basso; Marta Hernandez; Emilio Ortega; Nuria Alonso; Didac Mauricio; Angelo Avogaro; Giulio Ceolotto; Saula Vigili de Kreutzenberg
doi : 10.2337/dc22-1441
Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders
Mark R. Rigby; Beverly Hayes; Yinglei Li; Frank Vercruysse; Joseph A. Hedrick; Teresa Quattrin
doi : 10.2337/dc22-0908
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
Jon Edqvist; Christina Lundberg; Karin Andreasson; Lena Björck; Pigi Dikaiou; Johnny Ludvigsson; Marcus Lind; Martin Adiels; Annika Rosengren
doi : 10.2337/dc22-1760
Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion
Mary M. Barker; Melanie J. Davies; Francesco Zaccardi; Emer M. Brady; Andrew P. Hall; Joseph J. Henson; Kamlesh Khunti; Amelia Lake; Emma L. Redman; Alex V. Rowlands; Jane Speight; Tom Yates; Jack A. Sargeant; Michelle Hadjiconstantinou
doi : 10.2337/dc22-1237
Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy
Ravi Retnakaran; Chang Ye; Anthony J. Hanley; Philip W. Connelly; Mathew Sermer; Bernard Zinman
doi : 10.2337/dc22-1786
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial
Viktor Rotbain Curovic; Niels Jongs; Marjolein Y.A.M. Kroonen; Emilie H. Zobel; Tine W. Hansen; Taha Sen; Gozewijn D. Laverman; Adriaan Kooy; Frederik Persson; Peter Rossing; Hiddo J.L. Heerspink
doi : 10.2337/dc22-1699
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Jelle M. Beernink; Frederik Persson; Niels Jongs; Gozewijn D. Laverman; Glenn M. Chertow; John J.V. McMurray; Anna Maria Langkilde; Ricardo Correa-Rotter; Peter Rossing; C. David Sjöström; Robert D. Toto; David C. Wheeler; Hiddo J.L. Heerspink
doi : 10.2337/dc22-1514
Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY)
Marilyn Arosemena; Maria V. Salguero; Rochelle N. Naylor; Kristen Wroblewski; Esra Tasali; Louis H. Philipson
doi : 10.2337/dc22-1343
Rural Residence Is Associated With a Delayed Trend Away From Sulfonylurea Use for Treatment Intensification of Type 2 Diabetes
Danielle K. Nagy; Lauren C. Bresee; Dean T. Eurich; Scot H. Simpson
doi : 10.2337/dc22-1223
Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011–2021
Joseph R. Herges; Rodolfo J. Galindo; Joshua J. Neumiller; Herbert C. Heien; Guillermo E. Umpierrez; Rozalina G. McCoy
doi : 10.2337/dc22-1564
Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections
Alisa Boucsein; Antony S. Watson; Carla M. Frewen; Olivia J. Sanders; Jillian J. Haszard; Shirley D. Jones; Philippa J. Milford-Hughes; Martin I. de Bock; Benjamin J. Wheeler
doi : 10.2337/dc22-1971
Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997–2017)
Annika Vestergaard Kvist; Mohamad I. Nasser; Peter Vestergaard; Morten Frost; Andrea M. Burden
doi : 10.2337/dc22-1004
Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies
Tauseef A. Khan; David Field; Victoria Chen; Suleman Ahmad; Sonia Blanco Mejia; Hana Kahleová; Dario Rahelić; Jordi Salas-Salvadó; Lawrence A. Leiter; Matti Uusitupa; Cyril W.C. Kendall; John L. Sievenpiper
doi : 10.2337/dc22-1024
SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY
Shigeru Suzuki; Takahide Kokumai; Akiko Furuya; Satoru Takahashi
doi : 10.2337/dc22-1573
Assessment for Gender Differences in Trend in Age at Diagnosis of Diabetes Among U.S. Adults, 1999–2020
Anna R. McPherson; Michael P. Bancks
doi : 10.2337/dc22-1572
Prevalence of Albuminuria Among Adults With Diabetes and Preserved Estimated Glomerular Filtration Rate by Race and Ethnicity
Uchenna A. Nwosu; Jeanne A. Darbinian; Kenneth K. Chen; Billy Zeng; Hasmik Arzumanyan; Joan C. Lo; Sijie Zheng
doi : 10.2337/dc22-1871
Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes
Erika B. Parente; Stefan Mutter; Lena M. Thorn; Valma Harjutsalo; Per-Henrik Groop; FinnDiane Study Group
doi : 10.2337/dc22-1935
Concordance of A1C, Fasting Glucose, and Oral Glucose Tolerance Test Criteria for Defining Remission of Diabetes
Ravi Retnakaran; Jiajie Pu; Alexandra Emery; Caroline K. Kramer; Bernard Zinman
doi : 10.2337/dc22-2406
Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421
José-Miguel González-Clemente; Gemma Llauradó; Albert Cano; Olga Giménez-Palop; Lara Albert; Joan Vendrell
doi : 10.2337/dc22-2344
Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421
Tonet Serés-Noriega; Laura Boswell; Verónica Perea; Antonio J. Amor
doi : 10.2337/dci22-0061
